Assessment of neurobehavioral and biochemical effects in rats exposed to copper smelter dusts

Journal of Environmental Science and Health - Part A Toxic/Hazardous Substances and Environmental Engineering

Volumn 46, Issue 3, 2011, Pages 230-241

  Halatek, Tadeusz ^a   Lutz, Piotr ^a   Krajnow, Aleksander ^a   Stetkiewicz, Jan ^a   Domeradzka, Katarzyna ^a   Swiercz, Radoslaw ^a   Wasowicz, Wojciech ^a  

^a NOFER INSTITUTE OF OCCUPATIONAL MEDICINE   (Poland)

Author keywords

Clara cell protein; Copper smelter; dust; metals; neurobehavioral; rats

Indexed keywords

ANTI-INFLAMMATORIES; AVOIDANCE TESTS; BIOCHEMICAL EFFECTS; BIOCHEMICAL TESTS; BRONCHOALVEOLAR LAVAGE FLUID; CELL MORPHOLOGY; CELL PROTEINS; CELL VIABILITY; CONTROL GROUPS; DUST SAMPLES; FEMALE WISTAR RATS; INFLAMMATORY REACTION; MORPHOLOGICAL STUDY; NEUROBEHAVIORAL; PARTICULATE FRACTION; PARTICULATE MATTER; POST-EXPOSURE; PROTEIN CONCENTRATIONS; PROTEIN LEVEL; SMELTER DUST; SOLUBLE MATTERS; STERILE SALINE; TEST MATERIALS;

BEHAVIORAL RESEARCH; COPPER; DUST; PATHOLOGY; PROTEINS; RATS;

SMELTING;

ACETYLCHOLINE; CLARA CELL 16 PROTEIN; CLARA CELL PROTEIN; COPPER; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; CELL STRUCTURE; CELL VIABILITY; CLARA CELL; COGNITION; CONTROLLED STUDY; COPPER SMELTER; DUST EXPOSURE; FEMALE; HISTOPATHOLOGY; INFLAMMATION; LUNG; LUNG ALVEOLUS; LUNG INFILTRATE; LUNG LAVAGE; LUNG TOXICITY; MAZE TEST; MEMORY DISORDER; NEUROTOXICITY; NEUROTRANSMISSION; NONHUMAN; PARTICULATE MATTER; PASSIVE AVOIDANCE; PNEUMONIA; PROTEIN BLOOD LEVEL; RAT; SMELTER; WISTAR RAT;

ANALYSIS OF VARIANCE; ANIMALS; AVOIDANCE LEARNING; BRONCHOALVEOLAR LAVAGE FLUID; COPPER; DUST; FEMALE; INFLAMMATION; MAZE LEARNING; PARTICLE SIZE; PULMONARY ALVEOLI; RATS; RATS, WISTAR; TIME FACTORS; UTEROGLOBIN;

RATTUS; RATTUS NORVEGICUS;

EID: 79551608017     PISSN: 10934529     EISSN: 15324117     Source Type: Journal    
DOI: 10.1080/10934529.2011.535407     Document Type: Article

References (61)

1. Triebig, G.; Buttner, J. Neurotoxic occupational substances: I.Metals and their compounds. A literature review of the years 1970 to1982] Zentralbl Bakteriol Mikrobiol Hyg [B]. 1983, 177, 11-36.
2. Blom, S.; Lagerkvist, B.; Linderholm, H. Arsenic exposure to smelter workers. Clinical and neurophysiological studies. Scand. J. Work Environ. Health 1985, 11, 265-269.
3. Lagerkvist, B.J.; Zetterlund, B. Assessment of exposure to arsenic among smelter workers: a five-year follow-up. Am. J. Ind. Med. 1994, 25, 477-488.
4. Bolla-Wilson, K.; Bleecker, M.L. Neuropsychological impairment following inorganic arsenic exposure J. Occup. Med. 1987, 29, 500-503.
5. Morton, W.E.; Caron, G.A. Encephalopathy: an uncommon manifestation of workplace arsenic poisoning? Am. J. Ind. Med. 1989, 15, 1-5.
6. Martinez-Finley, E.J.; Ali, A.M.; Allan, A.M. Learning deficits in C57BL/6J mice following perinatal arsenic exposure: consequence of lower corticosterone receptor levels? Pharmacol. Biochem. Behav. 2009, 94, 271-277.
7. Flora, J.S.; Bhatt, K.;Mehta, A. Arsenic moiety in gallium arsenide is responsible for neuronal apoptosis and behavioral alterations in rats. Toxicol. Appl. Pharmacol. 2009, 240, 236-244.
8. Jarup, L.; Pershagen G.; Wall S. Cumulative arsenic exposure and lung cancer in smelter workers: A dose-response study. Am. J. Ind. Med. 1993, 15, 31-41.
9. Lee-Feldstein, A. Cumulative exposure to arsenic and its relationship to respiratory cancer among copper smelter employees. J.Ocup. Med. 1986, 28, 296-302.
10. Chia, S.E.; Phoon,W.H.; Lee,H.S.; Tan, K.T.; Jeyaratnam, J. Exposure to neurotoxic metals among workers in Singapore: an overview. Occup. Med. (Lond). 1993, 43, 18-22.
11. Kalia, K.; Flora, S.J. Strategies for safe and effective therapeutic measures for chronic arsenic and lead poisoning. J. Occup. Health 2005, 47, 1-21.
12. Lagerkvist, B.E.; Linderholm, H.; Nordberg,G.F.Arsenic andRaynaud's phenomenon. Vasospastic tendency and excretion of arsenic in smelter workers before and after the summer vacation. Int. Arch. Occup. Environ. Health 1988, 60, 361-4.
13. Garćia-Ch́avez, E.; Segura, B.; Merchant,H.; Jiḿenez, I.; DelRazo, L.M. Functional and morphological effects of repeated sodium arsenite exposure on rat peripheral sensory nerves. J.Neurol. Sci. 2007, 258, 104-110.
14. Monnet-Tschudi, F.; Zurich, M.G.; Boschat, C.; Corbaz, A.; Honegger, P. Involvement of environmental mercury and lead in the etiology of neurodegenerative diseases. Rev. Environ. Health 2006, 21, 105-117.
15. Chattopadhyay, S.; Bhaumik, S.; Purkayastha, M.; Basu, S.; Nag Chaudhuri, A.;Das Gupta, S.Apoptosis and necrosis in developing brain cells due to arsenic toxicity and protection with antioxidants. Toxicol. Lett. 2002, 136, 65-76.
16. Felix, K.; Manna, S.K.;Wise, K.; Barr, J.; Ramesh, G.T. Low levels of arsenite activates nuclear factor-kappaB and activator protein- 1 in immortalized mesencephalic cells. J. Biochem. Mol. Toxicol. 2005, 19, 67-77.
17. Husain, K.; Somani, S.M. Effect of exercise training and chronic ethanol ingestion on cholinesterase activity and lipid peroxidation in blood and brain regions of rat. Prog. Neuropsychopharmacol. Biol. Psychiatry. 1998, 22, 411-423.
18. Delwing, D.; Chiarani, F.; Wannmacher, C.M.; Wajner, M.; Wyse, A.T. Effect of hyperprolinemia on acetylcholinesterase and butyrylcholinesterase activities in rat. Amino. Acids. 2005, 28, 305-308.
19. Frampton, M.W. Does inhalation of ultrafine particles cause pulmonary vascular effects in humans? Inhal. Toxicol. 2007, 19(Suppl 1), 75-79.
20. Liu, H.H.; Lin,M.H.; Liu, P.C.; Chan, C.I.; Chen, H.L. Health risk assessment bymeasuring plasma malondialdehyde (MDA), urinary 8-hydroxydeoxyguanosine (8-OH-dG) and DNA strand breakage following metal exposure in foundry workers. J. Hazard. Mater. 2009, 170, 699-704.
21. Wilson, M.R.; Lightbody, J.H.; Donaldson, K.; Sales, J.; Stone, V. Interactions between ultrafine particles and transitionmetals in vivo and in vitro. Toxicol. Appl. Pharmacol. 2002, 184, 172-179.
22. Kitchin, K.T.; Conolly, R. Arsenic-induced carcinogenesis - oxidative stress as a possible mode of action and future research needs for more biologically based risk assessment. Chem. Res. Toxicol. 2010, 23, 327-335.
23. Dierynck, I.; Bernard, A.; Roels, H.; De Ley, M. The human Clara cell protein: biochemical and biological characterisation of a natural immunosuppressor. Mult. Scler. 1996, 1, 385-387.
24. Halatek, T.; Hermans, C.; Broeckaert, F.; Wattiez, R.; Wiedig, M.; Toubeau, G.; Falmagne, P.; Bernard. A. Quantification of Clara cell protein in rat and mouse biological fluids using a sensitive immunoassay. Eur. Respir. J. 1998, 11, 726-733.
25. Broeckaert, F.; Clippe, A.; Knoops, B.; Hermans, C.; Bernard, A. Clara cell secretory protein (CC16): features as a peripheral lung biomarker. Ann. NY Acad. Sci. 2000, 923, 68-77.
26. Steerenberg, P.A.; van Amelsvoort, L.; Lovik, M.; Hetland, RB.; Alberg, T.; Halatek, T.; Bloemen, H.J.; Rydzynski, K.; Swaen, G.; Schwarze, P.; Dybing, E.; Cassee, F.R. Relation between sources of particulate air pollution and biological effect parameters in samples from four European cities: an exploratory study. Inhal. Toxicol. 2006, 18, 333-346.
27. Oberdorster,G. Significance of particle parameters in the evaluation of exposure-dose-response relationships of inhaled particles. Inhal. Toxicol. 1996, 8(Suppl), 73-89.
28. Monteiller, C.; Tran, L.;MacNee,W.; Faux, S.; Jones, A.;Miller, B.; Donaldson, K. The pro-inflammatory effects of low-toxicity lowsolubility particles, nanoparticles and fine particles, on epithelial cells in vitro: the role of surface area. Occup. Environ. Med. 2007, 64, 609-615.
29. Vinzents, P.S.; Møller, P.; Sørensen, M.; Knudsen, L.E.; Hertel, O.; Jensen, F.P.; Schibye, B.; Loft, S. Personal exposure to ultrafine particles and oxidative DNA damage. Environ. Health. Perspect. 2005, 113, 1485-1490.
30. Nurkiewicz, T.R.; Porter, D.W.; Hubbs, A.F.; Stone, S.; Chen, B.T.; Frazer, D.G.; Boegehold, M.A.; Castranova, V. Pulmonary nanoparticle exposure disrupts systemic microvascular nitric oxide signalling. Toxicol. Sci. 2009, 110, 191-203.
31. Kwon, J.T.; Hwang, S.K.; Jin, H.; Kim, D.S.; Minai-Tehrani, A.; Yoon, H.J.; Choi, M.; Yoon, T.J.; Han, D.Y.; Kang, Y.W.; Yoon, B.I.; Lee, J.K.; Cho, M.H. Body distribution of inhaled fluorescent magnetic nanoparticles in the mice. J. Occup. Health 2008, 50, 1-6.
32. Sharma, H.S.; Ali, S.F.; Hussain, S.M.; Schlager, J.J.; Sharma, A. Influence of engineered nanoparticles from metals on the bloodbrain barrier permeability, cerebral blood flow, brain edema and neurotoxicity. An experimental study in the rat and mice using biochemical and morphological approaches. J. Nanosci. Nanotechnol. 2009, 9, 5055-5072.
33. Wang, Z.; Zhao, J.; Li, F.; Gao, D.; Xing, B. Adsorption and inhibition of acetylcholinesterase by different nanoparticles. Chemosphere 2009, 77, 67-73.
34. Chen, L.C.; Lippmann, M. Effects of metals within ambient air particulate matter (PM) on human health. Inhal Toxicol. 2009, 21, 1-31
35. Harkema, J.R.; Keeler, G.; Wagner, J.; Morishita, M.; Timm, E.; Hotchkiss, J.; Marsik, F.; Dvonch, T.; Kaminski, N.; Barr, E. Effects of concentrated ambient particles on normal and hypersecretory airways in rats. Res. Rep. Health Eff. Inst. 2004, 12, 1-68.
36. Lowry, O.H.; Rosenbrough, N.J.; Farr, A.L.; Randal, R.J. Protein measurement with folin-phenol reagent. J. Biol. Chem. 1951, 193, 265-275.
37. Bernard, A.; Lauwerys, R.; Noel, A.; Vandeleene, B.; Lambert, A. Determination by latex immunoassay of protein 1 in normal and pathological urine. Clin. Chim. Acta. 1991, 201, 231-245.
38. Hałatek, T.; Jakubowski, M. Latex immunologic methods of determining micro-molecular proteins and albumins in urine. Part I. Description of the method. Med. Pr. 1991, 42, 77-87.
39. Habig,W.; Pabst, M.; Jacoby,W. Glutathione S-transferase: the first step in mercapturic acid formation. J. Biol. Chem. 1970, 249, 7130-7139.
40. Gralewicz, S.; Wiaderna, D.; Tomas, T.; Rydzyóski, K. Behavioral changes following 4-week inhalation exposure to pseudocumene (1,2,4-trimethylbenzene) in the rat. Neurotoxicol. Teratol. 1997, 19, 327-333.
41. Gralewicz, S.;Wiaderna,D.; Lutz, P.; Sitarek,K.Neurobehavioural functions in adult progeny of rat mothers exposed to methylmercury or 2,2-, 4,4-, 5,5-hexachlorobiphenyl (PCB 153) alone or their combination during gestation and lactation. Int. J. Occup. Med. Environ. Health 2009, 22, 277-291.
42. Lutz, P.; Wiaderna, D.; Gralewicz, S.; Kur, B. Exposure to chlorphenvinphos, an organophosphate insecticide, prevents from behavioral sensitization to amphetamine. Int. J. Occup. Med. Environ. Health 2006, 19, 132-141.
43. Halatek, T.; Sinczuk-Walczak, H.; Rabieh, S.; Wasowicz, W. Association between occupational exposure to arsenic and neurological, respiratory and renal effects. Toxicol. Appl. Pharmacol. 2009, 239, 193-199.
44. Clarkson, T.W. Metal toxicity in the central nervous system. Environ. Health. Perspect. 1987, 75, 59-64.
45. Oteiza, P.I.; Mackenzie, G.G.; Verstraeten, S.V. Metals in neurodegeneration: involvement of oxidants and oxidant-sensitive transcription factors. Mol. Aspects. Med. 2004, 25, 103-115.
46. Aust, A.E.; Ball, J.C.; Hu, A.A.; Lighty, J.S.; Smith, K.R.; Straccia, A.M.; Veranth, J.M.; Young,W.C. Particle characteristics responsible for effects on human lung epithelial cells. Res. Rep. Health Eff. Inst. 2002, 110, 1-65.
47. Huang, Y.C.; Ghio, A.J.; Stonehuerner, J.; McGee, J.; Carter, J.D.; Grambow, S.C.; Devlin, R.B. The role of soluble components in ambient fine particles-induced changes in human lungs and blood. Inhal. Toxicol. 2003, 15, 327-342.
48. Halatek, T.; Opalska, B.; Lao, I.; Stetkiewicz, J.; Rydzyóski, K. Pneumotoxicity of dust from aluminum foundry and pure alumina: a comparative study of morphology and biomarkers in rats. Int. J. Occup. Med. Environ. Health 2005, 18, 59-70.
49. Wattiez, R.; Nöel-Georis, I.; Cruyt, C.; Broeckaert F.; Bernard, A.; Falmagne, P. Susceptibility to oxidative stress: proteomic analysis of bronchoalveolar lavage from ozone-sensitive and ozone-resistant strains of mice. Proteomics 2003, 3, 658-665.
50. Das, U.N. Acetylcholinesterase and butyrylcholinesterase as possible markers of low-grade systemic inflammation. Med. Sci. Monit. 2007, 13, 214-221.
51. Carreiras, M.C.; Marco, J.L. Recent approaches to novel anti- Alzheimer therapy. Curr Pharm Des 2004, 10, 3167-3175.
52. Lane, R.M.; Potkin, S.G.; Enz, A. Targeting acetylcholinesterase and butyrylcholinesterase in dementia. Int. J. Neuropsychopharmacol. 2006, 9, 101-124.
53. Niwa, Y.; Hiura, Y.; Sawamura, H.; Iwai, N. Inhalation exposure to carbon black induces inflammatory response in rats. Circ. J. 2008, 72, 144-149.
54. Cullen, R.T.;Tran,C.L.;Buchanan,D.;Davis, J.M.; Searl, A.; Jones, A.D.; Donaldson, K. Inhalation of poorly soluble particles. I. Differences in inflammatory response and clearance during exposure. Inhal. Toxicol. 2000, 12, 1089-1111.
55. Tran,C.L.; Buchanan,D.; Cullen, R.T.; Searl,A.; Jones, A.D.; Donaldson, K. Inhalation of poorly soluble particles. II. Influence Of particle surface area on inflammation and clearance. Inhal. Toxicol. 2000, 12, 1113-1126.
56. Yadav, R.S.; Sankhwar, M.L.; Shukla, R.K.; Chandra, R.; Pant, A.B.; Islam, F.; Khanna, V.K. Attenuation of arsenic neurotoxicity by curcumin in rats. Toxicol. Appl. Pharmacol. 2009, 240, 367-376.
57. Rodríguez, V.M.; Carrizales, L.;, Mendoza, M.S.; Fajardo, O.R.; Giordano, M. Effects of sodium arsenite exposure on development and behavior in the rat. Neurotoxicol. Teratol. 2002, 24, 743-750.
58. Luo, J.H.; Qiu, Z.Q.; Shu,W.Q.; Zhang, Y.Y.; Zhang, L.; Chen, J.A. Effects of arsenic exposure from drinking water on spatial memory, ultra-structures and NMDAR gene expression of hippocampus in rats. Toxicol. Lett. 2009, 184, 121-125.
59. Patlolla, A.K.; Tchounwou, P.B. Serum acetyl cholinesterase as a biomarker of arsenic induced neurotoxicity in sprague-dawley rats. Int. J. Environ. Res. Public Health 2005, 2, 80-83.
60. Bensoussan, H.; Grancolas, L.; Dhieux-Lestaevel, B.; Delissen, O.; Vacher, C.M.; Dublineau, I.; Voisin, P.; Gourmelon, P.; Taouis, M.; Lestaevel, P. Heavy metal uranium affects the brain cholinergic system in rat following sub-chronic and chronic exposure. Toxicology 2009, 261, 59-67.
61. Lutz, W.; Sułkowski, W.J. Vagus nerve participates in regulation of the airways: inflammatory response and hyperreactivity induced by occupational asthmogens. Int. J. Occup. Med. Environ. Health 2004, 17, 417-431.